The burgeoning popularity of semaglutide, often recognized by brand names like copyright and Wegovy, has sparked significant attention regarding its impact for fat management. Initially created for treating adult diabetes, its significant tendency to promote fullness and reduce appetite has led to its widespread use—both prescribed and sometimes